Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Bevolkingsonderzoek darmkanker leidt bij 3,6 procent tot diagnose
okt 2014